The Centers for Medicare & Medicaid Services (CMS) last year proposed to transition coverage of oral or injectable HIV pre-exposure prophylaxis (PrEP) drugs from Medicare Part D to Part B. PrEP drugs are approved by the Food and Drug Administration (FDA) to prevent HIV infection.
Now, to ensure patients have uninterrupted access to their medications, CMS is encouraging physicians and other Part B providers to start preparing their billing systems to submit claims for PrEP drugs and related counseling. That way, they can immediately transition to Part B coverage if CMS releases a final National Coverage Decision.
CMS anticipates that physicians and other providers will use the following HCPCS codes to report PrEP-related work:
A diagnosis code is required to report the above codes to Medicare, so physicians will also want to be aware of the new diagnosis code Z29.81, “Encounter for HIV pre-exposure prophylaxis.”
Review the CMS fact sheet (PDF) to learn more about how you can prepare for the possible upcoming coverage change, including information about enrollment, billing, claims processing, and coding.
— Kent Moore, AAFP Senior Manager, Payment Strategies
Posted on April 22, 2024
Sign up to receive FPM's free, weekly e-newsletter, "Quick Tips & Insights," featuring practical, peer-reviewed advice for improving practice, enhancing the patient experience, and developing a rewarding career.
Disclaimer: The opinions and views expressed here are those of the authors and do not necessarily represent or reflect the opinions and views of the American Academy of Family Physicians. This blog is not intended to provide medical, financial, or legal advice. Some payers may not agree with the advice given. This is not a substitute for current CPT and ICD-9 manuals and payer policies. All comments are moderated and will be removed if they violate our Terms of Use.